PLA2G7 antibody

Catalog No. ABIN7176818

Product Details anti-PLA2G7 Antibody

Target: PLA2G7 (Lp-PLA2) (Lipoprotein-Associated phospholipase A2 (Lp-PLA2))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This PLA2G7 antibody is un-conjugated

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Cross-Reactivity: Human, Mouse

Purification: Protein G purified

Immunogen: Recombinant LP-PLA2 Protein

Clone: 2A1B6

Isotype: IgG1, IgG1 kappa

Application Details

Application Notes: Recommended dilution:WB:1:500-1:5000,IHC:1:50-1:500,

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C,-80 °C

Storage Comment: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Details for PLA2G7

Target: PLA2G7 (Lp-PLA2) (Lipoprotein-Associated phospholipase A2 (Lp-PLA2))

Alternative Name: PLA2G7 (Lp-PLA2 Products)

Synonyms: LDL-PLA2 antibody, LP-PLA2 antibody, PAFAD antibody, PAFAH antibody, Lp-PLA2 antibody, PAF-AH antibody, R75400 antibody, zgc:77563 antibody, phospholipase A2 group VII antibody, phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) antibody, PLA2G7 antibody, Pla2g7 antibody, pla2g7 antibody

Background:

Background: Platelet-activating factor acetylhydrolase deficiency (PAFAD) : An enzymatic deficiency that results in exacerbated bodily response to inflammatory agents. It can be associated with several disease states including inflammatory gastrointestinal disorders, asthma and atopy. Asthmatic individuals with PAFAD may manifest aggravated respiratory symptoms.

Aliases: PLA2G7, PAFAH, LP-PLA2

UniProt: Q13093

Pathways: Peptide Hormone Metabolism